An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
Clinical trial NCT00599196 · COMPLETED
Trial details
- NCT number
- NCT00599196
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2008-12-01
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.